Eurofins Pharma Bioanalytics Services US, LLC

Eurofins Pharma Bioanalytics Services US LLC Part of Eurofins Central Lab US Holdings, Inc.

UEI
JL23CDPHLER3
CAGE
7B1Z5
Primary NAICS
621511 Medical Laboratories
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date
Website
eurofinsus.com
Founded
1987
Employees
50K-100K
Estimated annual revenue
$1B-$10B
Industry
  1. Industrials
  2. Commercial & Professional Services
  3. Professional Services
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Eurofins Pharma Bioanalytics Services US, LLC's 3 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Laboratory analysis Contract · 75N91025P00244 National Cancer Institute $12,075
Laboratory analysis Contract · 75N91025P00153 National Cancer Institute $12,075
Laboratory analysis Contract · 75N91024P00496 National Cancer Institute $11,075

About Eurofins Pharma Bioanalytics Services US, LLC

Eurofins Pharma Bioanalytics Services US, LLC is a foreign-owned, for-profit corporate entity registered in the System for Award Management (SAM) since January 8, 2015, with its registration set to expire on January 15, 2026. Located in St. Charles, Missouri, the company specializes in providing laboratory analysis services to federal agencies, with a primary focus on scientific and research-oriented support. While specific details about the company's full portfolio are not provided in the available data, the vendor appears to be a specialized laboratory services provider targeting scientific research institutions and government agencies.

The company has been awarded multiple federal contracts exclusively from the National Cancer Institute (NCI), all of which are purchase order contracts for laboratory analysis services. These contracts are consistently valued between $11,075.00 and $12,075.00, with performance periods ranging from June 30, 2024 to March 19, 2026. Each contract follows a firm fixed-price structure and does not utilize any specific set-aside designations. The laboratory analysis services appear to be targeted toward supporting scientific research, with a specific geographic focus on Rockville, Maryland. None of the current contract awards indicate the use of federal contract vehicles, prime contract awards, or grant prime awards, suggesting Eurofins Pharma Bioanalytics Services US, LLC operates as a direct service provider to the NCI for specialized laboratory analysis needs.

Quick answers

What is Eurofins Pharma Bioanalytics Services US, LLC's UEI?

Eurofins Pharma Bioanalytics Services US, LLC's Unique Entity ID (UEI) in SAM.gov is JL23CDPHLER3.

What is Eurofins Pharma Bioanalytics Services US, LLC's CAGE code?

Eurofins Pharma Bioanalytics Services US, LLC's CAGE code is 7B1Z5.

What is Eurofins Pharma Bioanalytics Services US, LLC's primary NAICS code?

Eurofins Pharma Bioanalytics Services US, LLC's primary NAICS code is 621511 (Medical Laboratories).

Is Eurofins Pharma Bioanalytics Services US, LLC registered in SAM.gov?

Eurofins Pharma Bioanalytics Services US, LLC's SAM.gov registration expired on January 15, 2026.

Who is Eurofins Pharma Bioanalytics Services US, LLC's parent company?

Eurofins Pharma Bioanalytics Services US, LLC is part of Eurofins Central Lab US Holdings, Inc.

What is Eurofins Pharma Bioanalytics Services US, LLC's most recent federal award?

Eurofins Pharma Bioanalytics Services US, LLC's most recent federal contract award is Laboratory analysis (75N91025P00244), from National Cancer Institute, on March 20, 2025.

On GovTribe

See Eurofins Pharma Bioanalytics Services US, LLC's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors